BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21790281)

  • 1. The pleomorphism of systemic sclerosis: are we ready for 'personalized medicine' in scleroderma?
    Steen VD
    Expert Rev Clin Immunol; 2011 Jul; 7(4):403-5. PubMed ID: 21790281
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel insights in the pathogenesis of systemic sclerosis.
    Radstake TR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):389-90. PubMed ID: 21790277
    [No Abstract]   [Full Text] [Related]  

  • 3. Translational medicine promising personalized therapy in oncology.
    Zeng YX; Zhang XS; Liu Q
    Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
    [No Abstract]   [Full Text] [Related]  

  • 4. How genetic variation affects patient response and outcome to therapy for psoriasis.
    Woolf RT; Smith CH
    Expert Rev Clin Immunol; 2010 Nov; 6(6):957-66. PubMed ID: 20979559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ancestry, ancestry-informative markers, asthma, and the quest for personalized medicine.
    Barnes KC
    J Allergy Clin Immunol; 2010 Dec; 126(6):1139-40. PubMed ID: 21134571
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted medications. New focus on companion tests.
    Reinke T
    Manag Care; 2012 Feb; 21(2):35-8. PubMed ID: 22393602
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies and clinical subsets: relevance to scleroderma.
    Maddison PJ
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):684-6. PubMed ID: 11020957
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcript profiling towards personalised medicine in rheumatoid arthritis.
    Verweij CL
    Neth J Med; 2009 Dec; 67(11):364-71. PubMed ID: 20009112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personalized medicine in rheumatology].
    Szekanecz Z
    Orv Hetil; 2013 Mar; 154(13):483-96. PubMed ID: 23524232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of pharmacogenetics in clinical practice is challenging.
    van Schie RM; de Boer A; Maitland-van der Zee AH
    Pharmacogenomics; 2011 Sep; 12(9):1231-3. PubMed ID: 21919599
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
    Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
    Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Getting personal.
    Nature; 2011 May; 473(7347):253-4. PubMed ID: 21593815
    [No Abstract]   [Full Text] [Related]  

  • 13. Translation towards personalized medicine in Multiple Sclerosis.
    Miller A; Avidan N; Tzunz-Henig N; Glass-Marmor L; Lejbkowicz I; Pinter RY; Paperna T
    J Neurol Sci; 2008 Nov; 274(1-2):68-75. PubMed ID: 18789804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenomics: hype or hope?].
    Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
    Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personalized medicine and molecular targets of drugs].
    Nishiyama M
    Nihon Rinsho; 2010 Oct; 68(10):1917-22. PubMed ID: 20954340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of scleroderma: implications for personalized medicine?
    Assassi S; Radstake TR; Mayes MD; Martin J
    BMC Med; 2013 Jan; 11():9. PubMed ID: 23311619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human genome 10th anniversary. Waiting for the revolution.
    Marshall E
    Science; 2011 Feb; 331(6017):526-9. PubMed ID: 21292950
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
    Koenig M; Dieudé M; Senécal JL
    Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding systemic sclerosis through gene expression profiling.
    Pendergrass SA; Whitfield ML; Gardner H
    Curr Opin Rheumatol; 2007 Nov; 19(6):561-7. PubMed ID: 17917536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
    Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
    Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.